重症监护病房获得的弱点:最近的见解
1Department of General Intensive Care Unit, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.
Journal of intensive medicine
|January 24, 2024
概括
在重症监护室获得的虚弱 (ICU-AW) 是重症患者经常出现的并发症,导致呼吸时间延长和死亡率更高. 本综述探讨了其风险因素,病理生理学,诊断和治疗,以供未来研究.
科学领域:
- 关键护理医学 关键护理医学
- 神经学 神经学
- 物理医学和康复 康复
背景情况:
- 在重症监护室获得的虚弱 (ICU-AW) 是重症患者中普遍存在的并发症.
- ICU-AW与不良结果有关,例如延长机械通风,延长ICU停留时间,增加死亡率 (ICU,住院和1年),以及更高的医疗保健成本.
研究的目的:
- 审查了解ICU-AW的最新进展.
- 探索ICU-AW的风险因素,病理生理学,诊断方法和治疗策略.
- 为未来ICU-AW的研究提供新的视角.
主要方法:
- 这项研究是对ICU-AW最近文献的综述.
- 它综合了关于ICU-AW各种方面的信息,包括其流行病学,临床影响和管理.
主要成果:
- 多种风险因素导致ICU-AW,包括晚年,并发症,疾病严重程度,器官衰竭,败血症,固定和机械通风.
- ICU-AW的潜在病理机制是复杂的,并没有完全阐明.
- 目前对诊断和治疗策略的理解正在不断发展.
结论:
- 在重症监护机构,ICU-AW带来了重大挑战.
- 需要进一步的研究来澄清病理生理学,并优化ICU-AW的诊断和治疗方法.
- 改善ICU-AW的理解和管理对于改善患者的治疗结果至关重要.
相关概念视频
Disorders of the Skeletal Muscle
953
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
953
Pneumonia III: Complications and Assessment
225
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
225
Myasthenia Gravis: Diagnostic Tests
844
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
844
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Acute Respiratory Failure-II
236
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
236
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K


